Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Inflammatory Bowel Diseases|August 20, 2020
Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the MicrobiotaClio P Mavragani, Adrianos Nezos, Nikolas Dovrolis, et al.Journal of Autoimmunity|July 18, 2015
Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesisAdrianos Nezos, Fotini Gravani, Anna Tassidou, et al.Frontiers in Immunology|October 30, 2020
Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic SclerosisNikolaos I Vlachogiannis, Maria Pappa, Panagiotis A Ntouros, et al.Current Issues in Molecular Biology|October 26, 2022
Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular CarcinomaAthanasios Armakolas, Vasiliki Dimopoulou, Adrianos Nezos, et al.Anticancer Research|December 27, 2011
IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cellsAnastassios Philippou, Athanasios Armakolas, Zacharoula Panteleakou, et al.Clinical Immunology (Orlando, Fla.)|December 16, 2020
Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunityClio P Mavragani, Kyriakos A Kirou, Adrianos Nezos, et al.Journal of Clinical Medicine|February 11, 2021
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's SyndromeEvangelia Argyriou, Adrianos Nezos, Petros Roussos, et al.Rheumatology (Oxford, England)|September 29, 2019
Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral centerAdrianos Nezos, Ourania D Argyropoulou, Eleni Klinaki, et al.Journal of Autoimmunity|July 13, 2013
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndromeAdrianos Nezos, Aristea Papageorgiou, George Fragoulis, et al.Clinical Immunology (Orlando, Fla.)|June 5, 2021
Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus ErythematosusPanagiotis A Ntouros, Nikolaos I Vlachogiannis, Maria Pappa, et al.Pageof 5